Hatta Waku, Kumagai Shinji, Imamura Junji, Oikawa Tomoyuki, Asano Yasunari, Fujita Hiroshi, Aizawa Hiroki, Kaneko Kenzo, Kayaba Shouichi, Sawada Masashi, Kusuda Kazuyuki, Suzuki Yu, Takehana Kou, Endo Yoshihiro, Kitamura Michihiko, Kimizuka Goro
Dept. of Internal Medicine, Isawa Hospital.
Gan To Kagaku Ryoho. 2005 Jun;32(6):855-8.
A 73-year-old woman was admitted to our hospital for evaluation of hypochondralgia, and a thorough examination revealed an AFP producing gastric cancer with multiple liver metastases. One course of TS-1 100 mg/day for 4 weeks and discontinuation for 2 weeks was started from February, 2003. After 3 months, the level of AFP reduced remarkably from 53,700 ng/ml to the normal limit. The metastatic tumors in the liver showed regression, and after 14 months, CT scanning showed that the tumors had disappeared. Since the size of the original tumor showed no change, distal gastrectomy was performed, and curability A was achieved. We consider this rare case has significant value in terms of treatment of AFP producing gastric cancer with multiple liver metastases. We think the combination of surgery and chemotherapy such as TS-1 will lead to a better prognosis in such cases.
一名73岁女性因季肋部疼痛入院,全面检查发现为产生甲胎蛋白的胃癌伴多发肝转移。从2003年2月开始给予替吉奥(TS-1)100毫克/天,持续4周,停药2周。3个月后,甲胎蛋白水平从53700纳克/毫升显著降至正常范围。肝脏转移瘤出现消退,14个月后CT扫描显示肿瘤消失。由于原发肿瘤大小未变,遂行远端胃切除术,达到A期治愈。我们认为这个罕见病例对于伴有多发肝转移的产生甲胎蛋白的胃癌治疗具有重要价值。我们认为手术与替吉奥等化疗联合应用在此类病例中会带来更好的预后。